276 related articles for article (PubMed ID: 27278788)
1. Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.
Kato M; Kurozumi A; Goto Y; Matsushita R; Okato A; Nishikawa R; Fukumoto I; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2017 Jan; 62(1):123-132. PubMed ID: 27278788
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.
Kato M; Goto Y; Matsushita R; Kurozumi A; Fukumoto I; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Int J Oncol; 2015 Aug; 47(2):710-8. PubMed ID: 26063484
[TBL] [Abstract][Full Text] [Related]
4. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
Kamikawaji K; Seki N; Watanabe M; Mataki H; Kumamoto T; Takagi K; Mizuno K; Inoue H
J Hum Genet; 2016 Dec; 61(12):985-993. PubMed ID: 27488440
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187
[TBL] [Abstract][Full Text] [Related]
6. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
8. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
Wang D; Lu G; Shao Y; Xu D
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28188157
[TBL] [Abstract][Full Text] [Related]
9. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
10. Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.
Nishikawa R; Chiyomaru T; Enokida H; Inoguchi S; Ishihara T; Matsushita R; Goto Y; Fukumoto I; Nakagawa M; Seki N
FEBS Lett; 2015 Jul; 589(16):2136-45. PubMed ID: 26096783
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HCP5 promotes osteosarcoma cell proliferation, invasion, and migration via the miR-29b-3p-LOXL2 axis.
Tan JD; Zhou MF; Yang S; Lin JP
Kaohsiung J Med Sci; 2022 Oct; 38(10):960-970. PubMed ID: 35899856
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a Inhibits the Cell Viability and Metastasis of Prostate Cancer by Targeting SOX4.
Liao G; Xiong H; Tang J; Li Y; Liu Y
Technol Cancer Res Treat; 2020; 19():1533033820959354. PubMed ID: 32930086
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.
Nishikawa R; Goto Y; Kojima S; Enokida H; Chiyomaru T; Kinoshita T; Sakamoto S; Fuse M; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2014 Jul; 45(1):401-10. PubMed ID: 24820027
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
16. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.
Kojima S; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nohata N; Fuse M; Ichikawa T; Naya Y; Nakagawa M; Seki N
Br J Cancer; 2012 Jan; 106(2):405-13. PubMed ID: 22068816
[TBL] [Abstract][Full Text] [Related]
17. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
18. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
20. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
Ye MF; Zhang JG; Guo TX; Pan XJ
Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
